Pharmacy Podcast Network

Express Scripts Fails to Defeat Louisiana Prescription Fee Suit | PBM Reform Podcast Series

LIPA v ESI: Fight for the Right to Be Paid 
What happens when a state implements provider fee statutes that are officially approved by CMS but one of the big 3 PBMs still claims exemption?
Join guest host Monique Whitney with special guests Randal Johnson, JR Whaley, and MJ Terrebonne as they discuss Louisiana's legal battle with ESI over 10 cents per claim, and the ramifications this could have on state Medicaid programs nationwide.
Host: 
Monique Whitney, Executive Director, Pharmacists United for Truth & Transparency 
Guests:  
Randal Johnson, CEO, Louisiana Independent Pharmacies Association 
JR Whaley, Legal Counsel, Louisiana Independent Pharmacies Association 
MJ Terrebonne, Health Policy Expert & retired Director of Pharmacy, Louisiana Medicaid
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Dynamics of 340B Program Spotlight the Value of Strong Pharmacy-Finance Partnerships | Future of Pharmacy Podcast

Learn how health systems can leverage a vibrant, pharmacy-finance partnership to drive successful 340B programs, and allow pharmacy staff more time to focus on patient care. Find out why 340B program management has evolved, the program challenges that health systems still face, and the data and operational complexities that necessitate a cross-functional approach.
Guests:                     
Eric Iorfido, PharmD, 340B Program Manager, Penn Highlands DuBois, PA
Charles Hirner, RPh, Senior Director, Omnicell 340B Operations
Host:                         
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Tennessee Senator Shane Reeves | PBM Reform Podcast Series

Tennessee Gov. Bill Lee signed HB 786, a comprehensive PBM reform bill that strengthens existing fair pharmacy audit laws, limits PBM adjudication fees, and prohibits a PBM from reimbursing a pharmacy less than it reimburses a PBM-affiliated pharmacy.May 30, 2019
Tennessee SB650
Present law defines "pharmacy benefits manager" (PBM) to mean a person, business, or other entity and any wholly or partially owned subsidiary of the entity, that administers the medication and/or device portion of pharmacy benefits coverage provided by a health insurance plan, subject to certain exceptions.
Present law provides detailed requirements for the conduct of an audit of records of a pharmacist or pharmacy by a health insurance plan, a PBM, the state or its political subdivisions, or any other entity representing the same. One such audit requirement is that a clerical or recordkeeping error regarding a required document or record may not, in and of itself, constitute fraud; however, the claims may be subject to recoupment. This bill instead provides that a clerical or recordkeeping error identified during an audit is not prima facie evidence of fraud or intentional misrepresentation and must not be the basis of a recoupment unless the error results in an actual overpayment to the pharmacy or the wrong medication being dispensed to the patient. As under present law, a clerical error will not be subject to criminal penalties without proof of intent to commit fraud. 
Shane Reeves is an American businessman, pharmacist and politician who is the State Senator for the 14th District of Tennessee, which is composed of Bedford County, Moore County, Lincoln County, Marshall County, and part of Rutherford County. As a seventh-generation Tennessean, Senator Shane Reeves has spent his life raising a family and opening businesses in middle Tennessee. He understands the importance of family, character, and conservative values to the people in this community.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Good the Bad & the Ugly | GameChangers

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.
This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.
Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345
Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download 
CPE details for GameChangers Podcast April 2021
Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Flip the Pharmacy: 1 Year Later | Beyond the Sig

In March of 2020, we launched Beyond the Sig by hosting Randy McDonough, Director of Practice Transformation of Flip the Pharmacy, to discuss how the Flip the Pharmacy initiative was supporting pharmacies in practice transformation.  
During this episode of Beyond the Sig, PPCN Executive Director Stephanie McGrath sits down with Randy virtually to reflect on the past year, how Flip the Pharmacy has supported pharmacies through the COVID-19 pandemic, and highlight some of the brightest innovations demonstrated by participating pharmacies.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

NCPA 2020 Lifetime Achievement Award | Pharmacy Crossroads

Nasir Mahmood is a remarkable pharmacy owner.  Indeed, so remarkable that the NCPA named him the winner of the 2020 Lifetime Achievement Award.  And the list of honors and service he has provided to the profession and to his community justifies this high honor.
In this podcast Nasir and his son, Rehan, Mahmood share with Kneeland the PharmacyCrossRoads listeners several of the personal philosophy and business practices that allow Pine Plains Pharmacy, in Pine Plains, New York to be such an important part of this small community halfway between New York City and Albany, NY. 
Nasir, who also earned an MBA shared his view that knowing people, calling them by name and finding ways for the pharmacy to stock the special or unique items they want is one critical success factor.  While the pharmacy is small, just under 2000 sq. feet, he says they find ways to fit items into the pharmacy.  Adding to that idea is a robust special-order program where he says find his willingness to orders items an important customer service. 
Rehan tells how he worked with suppliers, the city’s fire department and created an appointment system that allowed them to provide this small town with a successful, and ongoing, COVID vaccination program. 
One heartfelt aspect of Nasir’s philosophy is giving back, thus he has served President and Chairman of the Pharmacist Society of the State of New York, winner of the Bowl of Hygiea Award, serves on the State Board of Pharmacy and is active in both NCPA and APhA. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Arrested Development, Cannabis & Adolescents | CRx Podcast

Arrested Development 
https://www.crxmag.com/issues/2021/winter/arrested-development.shtml
The related research letter published in JAMA Psychiatry on 3/27/2019 titled; Association of Prenatal Cannabis Exposure With Psychosis Proneness Among Children in the Adolescent Brain Cognitive Development (ABCD) Study. 
Jeremy Fine is entering medical school this fall was a key contributor behind the creation of this research letter. 
Association of Prenatal Cannabis Exposure With Psychosis Proneness Among Children in the Adolescent Brain Cognitive Development (ABCD) Study
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2729440
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Zolgensma, The Most Expensive Drug Ever | Lets Pharmonize

Description: Viagra, Crestor, Eliquis, and many other brand-name medications come to mind when the discussion turns to expensive drugs. These drugs are pocket change in comparison to Zolgensma, a new(ish) gene therapy for Spinal Muscular Atrophy that costs as much as a private island. Tune in as our hosts discuss this incredible drug and some of the ramifications of its incredible price tag.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music by FesliyanStudios
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Demonstrating Value Through A Patient Care Program | Beyond the Sig

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Eric Yarnell, Vice President of Pharmacy at Gateway Health. He brings both pharmacist and payer perspectives as a member of the Flip the Pharmacy Payer Advisory Board. In this conversation, Eric shares how Gateway Health has worked with a community pharmacy network to implement a patient care program and how community pharmacy enhanced services bring value to health plans.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Not All Heroes Wear Capes | Beyond the Sig

Skippack Pharmacy has been leading mass COVID-19 vaccination efforts in the Schwenksville, Pennsylvania community and their efforts have gained national attention. You might recognize Skippack’s owner as the Superman pharmacist recently featured on Good Morning America. Today, we will hear from two members of the Skippack team, who have been working behind the scenes to help Skippack Pharmacy administer over 10,000 COVID-19 vaccines.
On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Skippack Pharmacy intern, Erica Mabry, and American Pharmacists Association (APhA) Chief of Governance & State Affiliates and Executive Director of the APhA Foundation, Mitch Rotholz, who is the policy lead for immunizations for the profession. They share their experiences working together to coordinate these clinics and their perspectives on the future of community pharmacy practice transformation.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A Story of Innovation in Health System Pharmacy (01) | Allegheny Health Network

Chapter 1 of 3 
Featuring: Allegheny Health Network Pharmacy Services 
AHN overview and history
AHN Pharmacy Transformation – Patient – centered care planning
Becoming one team
Standardized practice / technology throughout all sites
Guests:
Laura (McCoy) Mark, PharmD - Vice President, Pharmacy
Arpit Mehta, Pharm.D., MPH, MHA - Director of Pharmacy
Kelley Wasicek, BS Pharm Director of Pharmacy
Rob Simpson, PharmD 
This podcast series is sponsored by Omnicell. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis Industry Election Victories | CRx Podcast

The cannabis industry won at the ballot box in the recent election, with four states passing laws to make cannabis legal for adults and two approving cannabis for medical purposes. These results moved the National Cannabis Industry Association (NCIA) closer to its goal of building a robust cannabis industry while supporting state laws and advocating for federal policy reforms.   
On November 3, 2020, voters in five states made a definitive statement about cannabis use. Arizona, Montana, New Jersey, and South Dakota approved adult use of cannabis. South Dakota also approved a medical initiative, along with Mississippi, which approved comprehensive cannabis medical options.  
The National Cannabis Industry Association (NCIA) has been working toward outcomes such as these since 2010. With 2,000 members nationwide, the organization is supporting the industry as cannabis becomes a thriving business and a real economic force. In recent years, NCIA has been a vocal advocate for social equity, working to promote expungement of criminal records of many people—largely from minority communities—who were unfairly incarcerated as part of the ill-conceived War on Drugs.
The results of the initiatives in these five states illustrate how far the industry has come. The people have spoken, and their voice was definitive.
“The margins were higher than we expected,” says Morgan Fox, spokesperson for NCIA. “In Arizona, there was a 60% margin, while the margin in New Jersey was 66%, 10 points higher than it was in California when it passed an adult use initiative in 2016. These results are not just political victories; they will likely have widespread ramifications. Importantly, it will be much more difficult for law enforcement to use cannabis as a weapon against minority populations. Instead, we will likely see more economic opportunities in the industry and fewer arrests overall.”
Although there were differences among the measures passed, those that supported legalization all set 21 as the legal age for use. In New Jersey, the law requires that the state set a regulatory structure, along with limits for possession and homegrown cannabis plants. Arizona established the number of plants allowed at six, while South Dakota limited cultivation to three. The law in Arizona also stated that the Department of Health Services must promote business ownership and industry participation among people from communities who have been harmed by former cannabis policies. Furthermore, a portion of cannabis tax revenue will be set aside for the newly created Justice Reinvestment Fund.    
To date, almost 34% of Americans live in states with laws establishing cannabis as legal and regulated for adults. Four of the five states that recently passed laws legalizing cannabis have been responsible for roughly 60,000 cannabis arrests each year, mostly for simple possession. On the economic side, researchers estimate that the combined value of the cannabis markets in these five states will climb to more than $3.1 billion by 2025. In states where cannabis is now legal, Congressional representation will increase by 29 representatives and eight senators.
In sum, cannabis is now legal for adults in 15 states, as well as the District of Columbia and the territories of CNMI and Guam. What’s more, 36 states and several territories have comprehensive medical cannabis laws. Cannabis is now legal in some form in 47 states in the United States.
Guests: 
David L. Nathan, MD, DFAPA
President, Board of Directors
Doctors for Cannabis Regulation
Abby Stoddard, PharmD, MBA 
The Client Centered Network
www.clientcn.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Cancer Pain Conundrum | CRx Podcast

Opioids play a critical role in managing cancer-associated pain, but they’re highly addictive, and they don’t always provide sufficient pain relief for cancer patients. Many patients therefore turn to cannabis or cannabis-derived products to help manage their pain, using them either as standalone treatments or as an adjuvant therapy to opioids. But does research support cannabis use for this purpose? The evidence is mixed, and some studies suggest there may indeed be benefits for cancer pain—but there’s also reason for caution.
How Much Research Is There?
There’s a relatively strong body of research on cannabis for the treatment of chronic pain generally, according to Eloise Theisen, RN, MSN, president of the American Cannabis Nurses Association and co-founder of Radicle Health, a cannabis education and advocacy organization. However, much of this research has focused on neuropathic pain in multiple sclerosis and spinal cord injuries, and comparatively few studies have examined pain in the cancer context. Among the studies that exist for cancer, many have small sample sizes, and study design is also an issue. “We have animal studies and some clinical human studies,” says Theisen, but there’s “a lack of randomized controlled trials, which are considered to be the gold standard.”
A further complicating factor in the research on cannabis and cancer pain is that most of the existing studies on this topic have relied on products that do not match those cancer patients actually use in practice. According to Hance Clarke, MD, PhD, associate professor of anesthesia at the University of Toronto and author of a recent review article on cannabis and pain,1 the products that have been studied most extensively are pharmaceutical-grade cannabis isolates, such as nabiximols (an extract containing THC and CBD in a precise one-to-one ratio), nabilone (synthetic THC), and dronabinol (also synthetic THC). However, cancer patients outside of the research context are much more likely to use dispensary cannabis and non-pharmaceutical-grade plant-based extracts. “We’re kind of stuck without enough evidence on the products that people are currently using,” says Clarke. This is important, because patients may react quite differently to a dispensary product than to a pharmaceutical product, according to Clarke.
Guests: 
Eloise Theisen, MSN, RN, is a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy. For over 20 years, Eloise has worked primarily with cancer, dementia and chronic pain patients. In the last several years, Eloise has focused her efforts on cannabinoid therapies. Eloise was one of the first healthcare professionals to bring a clinical dosing regimen to the cannabis space. In 2019, Eloise was elected President of the American Cannabis Nurses Association and will serve through 2022. In 2019, Eloise co-authored Pain Free with CBD: Everything You Need to Know and Effectively Use Cannabidiol with Alice O’Leary Randall.   
Joe Jeffries, Pharm D is currently Director of Pharmacy at FarmaceuticalRx, a medical cannabis dispensary in East Liverpool Ohio. Joe is the former Director of Pharmacy at Barnesville Hospital and was named the Healthcare Worker of the Year, largely for his creation of a program to help those struggling with drug addiction. Joe was also President of the Ohio Pharmacists Association from 2000-2001. 
Host: 
Joseph Friedman  CannaRPh Consultants
CRx Magazine Advisory Board, CRx Podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Don’t Stop Me Now | GameChangers

The battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now!
Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.
CPE details for GameChangers Podcast April 2021
Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections
0107-0000-21-158-H01-P
0.2 CEU/2 Hrs (Knowledge)
Initial Release Date: 04/06/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Commitment to Evidence Based Content Development | Bernadette Mazurek Melnyk PhD

Fascinating discussion with the Ohio State University's Chief Wellness Officer & author of Evidence-based Competencies in Healthcare, Dr. Bernadette Melnyk PhD about evidence-based practice of medicine and raising the standards of content development. 
Hospitals and healthcare systems around the world have attempted to build and sustain evidence-based practice (EBP) cultures and environments, yet they have struggled to clearly understand what EBP competency means. Implementing the Evidence-Based Practice (EBP) Competencies in Healthcare clears up that confusion and serves as a guide for clinicians, leaders, faculty, EBP mentors, and students in achieving EBP competency, facilitating evidence-based decision making in daily practice, and accelerating the speed at which research knowledge is translated into real-world settings to improve health outcomes and decrease healthcare costs.
We must develop content which is clinically focused in the same manner as practicing Evidence-based medicine. 
Implementing the Evidence-based Practice (EBP) Competencies in HealthcareA Practical Guide to Improving Quality, Safety, and Outcomes By Bernadette Mazurek Melnyk, Lynn Gallagher-Ford, Ellen Fineout-Overholt  
Bernadette Mazurek Melnyk, PhD, RN, CPNP/PMHNP, FAANP, FNAP, FAAN, is Associate Vice President for Health Promotion, University Chief Wellness Officer, and Professor and Dean of the College of Nursing at The Ohio State University (OSU) and Professor at OSU's College of Medicine.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

National Patient Counseling Competition | Future Pharmacy Leaders

Deanna J. Schnitzer is a pharmacy student the University of Pittsburgh School of Pharmacy. Deanna was a finalist for the National Patient Counseling Competition. 
The goal of the APhA-ASP National Patient Counseling Competition is to encourage student pharmacists in their efforts toward becoming better patient educators.
2021 National Patient Counseling Competition FINALISTS 
Anna Brown – University of North Carolina at Chapel Hill
Amy Chan – Virginia Commonwealth University
Sara Salama – Midwestern University, Downers Grove Campus
Deanna Schnitzer – University of Pittsburgh
Tammy Nguyen – The University of Kansas
Isabelle Tharp – Drake University
Madison Wiarek – University of Wisconsin – Madison
Alison Weygint – The University of Arizona
Allison Vu – University of California, San Diego
This episode is sponsored by the Ultiguard Safe Pack. 
UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., Learn more about the UltiGuard Safe Pack: https://www.ulticare.com/ultiguard-safe-pack/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacogenomics Rotation of Pharmacy Students | PGx for Pharmacists

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, Maci Koesterer, PharmD candidate 2021 from St. Louis College of Pharmacy where we discuss her first virtual and unique rotation in PGx and her recommendations to other students.
 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Thinking Outside the Box | PGx for Pharmacists

Behnaz Sarrami, MS, PharmD, an entrepreneur and a coach in PGx who has started her own consulting business bringing awareness to the clinical value and utility of PGx to providers, pharmacists, and consumers. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Using Data to End Racial Health Inequality & Improve Health Equity | Transforming a Nation Series

Translational Health Disparities Research in a Data-Rich World
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356140/
People experiencing health disparities, researchers, program and policy staff, and leaders addressing health policies present a spectrum of opinion about the value of big data approaches. These differing opinions range from lack of trust, to acceptance, to enthusiastic endorsement. Researchers must be cognizant and respectful of these differences because building trust is a key aspect of building a broad coalition, which is needed for successful generalizability. Moreover, researchers have the responsibility to ensure their research does not cause harm to either individuals or communities.
How Can Big Data Help to Address Health Disparities?
https://datascience.cancer.gov/news-events/blog/how-can-big-data-help-address-health-disparities
Our country is in the midst of two crises. One is the threat of the COVID-19 pandemic. The other has more historic underpinnings but is now finally receiving greater recognition—the issue of racial inequality.
Today’s Guest:
Dr. Claire Exaus earned a B. S. Pharmacy degree in 1997 from Massachusetts College of Pharmacy. Got licensed in MA and worked at Cambridge Hospital for two months then moved to FL in June of that year and took a position of staff pharmacist at a very busy CVS pharmacy then called Eckerd Drugs. Dr. Claire Exaus quickly attracted the attention of the district manager as customers called and wrote the district office of her outstanding customer service. Dr. Claire got promoted to pharmacist trainer in May 1998 and spent a month in Richmond, Virginia assisting with Rite Aid conversion to Eckerd Drugs after acquisition.
In January 2001, Dr. Claire enrolled back in school into an MBA program but quickly realized that it wasn’t for her. Her goal was to be a clinical pharmacist and instead obtained her PharmD.
Four years later in January 2005, Dr. Claire was accepted into the PharmD program at Nova Southeastern University with a concentration in Managed Care and found her footing. In May 2010, Dr. Claire graduated with Honors with her PharmD while maintaining a full-time job and caring for her new baby.
In 2007, Claire left retail pharmacy and took a position at a federally-funded HIV clinic where she provided care and education to newly diagnosed HIV patients and assisted them in getting HIV medications through patient-assisted medication programs funded by drug manufacturers. Two years later, the clinic closed due to lack of funding.
In March 2009, Claire entered the world of hospital pharmacy at Baptist Hospital in Miami, FL. It was there at that institution that her clinical formation took shape and there Dr. Claire got to fulfill her goals of honing in her clinical acumen. Always ready to learn, she was assigned to different floors and was mentored by the more experienced pharmacists. She rotated through med-surg, pediatric, pediatric oncology, surgery, emergency medicine, critical care and oncology.
She was recognized for improving SCIP score rate after 3 months on the surgery floor. She demonstrated her leadership by leading various projects to improve medication safety and employee wellness with organizing fundraising for the annual heart walk. In 2011, Dr. Claire was introduced to pharmacy informatics by participating in a project to roll out new dispensing cabinets to a new surgery wing.
The rollout was an eye opener to a new world of potentials. Shortly thereafter, Dr. Claire took a position at Palmetto Hospital as a Clinical Informatics Pharmacist as the hospital was preparing to transition from Meditech system to Cerner.
Dr. Claire volunteered to train as a super user to train others to use the system. Dr. Claire trained physicians, nurses and pharmacy staff. Learning this new skill opened the door to go back to school and obtain a degree in Healthcare Informatics.
In August 2015, Dr. Claire left Florida and moved to Massachusetts and took the position of Lead Clinical Pharmacist at Healthcare Associates. She developed a pharmacist-led prior authorization program.
In June 2019, Dr. Claire transferred to the Cancer Center where she held the title of Clinical Coordinator Oncology System Management. Currently, Dr. Claire is pursuing a Masters in Regulatory Affairs with a concentration in Health Economic Outcomes Research.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices